Showing results (1021-1030 of 2,824) with videos related to
Sort By:
Pageof 283
Cytotherapy|January 19, 2010
Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemiaMohammad Reza Zafarghandi, Hassan Ravari, Nasser Aghdami, et al.Cytotherapy|May 13, 2017
Safety profile and long-term engraftment of human CD31+ blood progenitors in bone tissue engineeringHadar Zigdon-Giladi, Rina Elimelech, Gal Michaeli-Geller, et al.Cytotherapy|May 23, 2009
The washouts of discarded bone marrow collection bags and filters are a very abundant source of hMSCsChiara Capelli, Agnese Salvade, Olga Pedrini, et al.Cytotherapy|February 27, 2009
Clinical-scale elutriation as a means of enriching antigen-presenting cells and manipulating alloreactivityKenneth P Micklethwaite, Frances M Garvin, Melina R Kariotis, et al.Cytotherapy|February 28, 2009
Evoked potential studies can only be interpreted as a neurophysiologic measure if applied accuratelySemai Bek, Erdal Eroglu, Zeki OdabasiCytotherapy|April 30, 2009
Proteomic profiling of human embryonic stem cell-derived microvesicles reveals a risk of transfer of proteins of bovine and mouse originI Kubikova, H Konecna, O Sedo, et al.Cytotherapy|December 18, 2008
How do mesenchymal stromal cells exert their therapeutic benefit?E M Horwitz, M DominiciCytotherapy|December 18, 2008
Natural killer cell immunotherapy for cancer: a new hopeS Srivastava, A Lundqvist, R W ChildsCytotherapy|October 7, 2008
Multipotent adult progenitor cells: their role in wound healing and the treatment of dermal woundsB J Herdrich, R C Lind, K W LiechtyCytotherapy|October 7, 2008
Immunomodulatory effects of imatinib and second-generation tyrosine kinase inhibitors on T cells and dendritic cells: an updateR Seggewiss, D A Price, M A PurbhooPageof 283